These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 34237822)

  • 21. Update on diagnosis, pathophysiology, and management of diabetic kidney disease.
    Sugahara M; Pak WLW; Tanaka T; Tang SCW; Nangaku M
    Nephrology (Carlton); 2021 Jun; 26(6):491-500. PubMed ID: 33550672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.
    Mazzieri A; Porcellati F; Timio F; Reboldi G
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
    Matoba K; Takeda Y; Nagai Y; Kawanami D; Utsunomiya K; Nishimura R
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation in Diabetic Kidney Disease.
    Pérez-Morales RE; Del Pino MD; Valdivielso JM; Ortiz A; Mora-Fernández C; Navarro-González JF
    Nephron; 2019; 143(1):12-16. PubMed ID: 30273931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGE/RAGE in diabetic kidney disease and ageing kidney.
    Wu XQ; Zhang DD; Wang YN; Tan YQ; Yu XY; Zhao YY
    Free Radic Biol Med; 2021 Aug; 171():260-271. PubMed ID: 34019934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials.
    Fernández Fernández B; Elewa U; Sánchez-Niño MD; Rojas-Rivera JE; Martin-Cleary C; Egido J; Ortiz A
    Minerva Med; 2012 Aug; 103(4):219-34. PubMed ID: 22805616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives.
    Wang Y; Jin M; Cheng CK; Li Q
    Front Endocrinol (Lausanne); 2023; 14():1238927. PubMed ID: 37600689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention.
    McGrath K; Edi R
    Am Fam Physician; 2019 Jun; 99(12):751-759. PubMed ID: 31194487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
    Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F487-F494. PubMed ID: 28468961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uric acid and risk of diabetic kidney disease.
    Mauer M; Doria A
    J Nephrol; 2020 Oct; 33(5):995-999. PubMed ID: 32651849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition.
    Patney V; Chaudhary K; Whaley-Connell A
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):158-165. PubMed ID: 29580580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
    Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
    Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease.
    Ambinathan JPN; Sridhar VS; Lytvyn Y; Lovblom LE; Liu H; Bjornstad P; Perkins BA; Lovshin JA; Cherney DZI
    J Diabetes Complications; 2021 May; 35(5):107880. PubMed ID: 33678512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular cell cross talk in diabetic kidney diseases.
    Dong R; Xu Y
    J Diabetes; 2022 Aug; 14(8):514-523. PubMed ID: 35999686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism.
    Liu T; Jin Q; Yang L; Mao H; Ma F; Wang Y; Li P; Zhan Y
    Front Endocrinol (Lausanne); 2023; 14():1142276. PubMed ID: 37635982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.
    Warren AM; Knudsen ST; Cooper ME
    Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
    Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic kidney disease: from physiology to therapeutics.
    Mora-Fernández C; Domínguez-Pimentel V; de Fuentes MM; Górriz JL; Martínez-Castelao A; Navarro-González JF
    J Physiol; 2014 Sep; 592(18):3997-4012. PubMed ID: 24907306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.